Current Radiopharmaceuticals
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 1
Author(s): Peter J. H. Scott
Affiliation:
Export Options
About this article
Cite this article as:
Scott J. H. Peter, Meet Our Editorial Board Member, Current Radiopharmaceuticals 2017; 10 (1) . https://dx.doi.org/10.2174/187447101001170308175951
DOI https://dx.doi.org/10.2174/187447101001170308175951 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Current Alzheimer Research New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Medical Management of Parkinsons Disease: Focus on Neuroprotection
Current Neuropharmacology Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Zolpidem Therapy for Movement Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Pathways by Which Aβ Facilitates Tau Pathology
Current Alzheimer Research Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems
CNS & Neurological Disorders - Drug Targets Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry The Framingham Brain Donation Program: Neuropathology Along the Cognitive Continuum
Current Alzheimer Research Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery Tau as a Molecular Marker of Development, Aging and Neurodegenerative Disorders
Current Aging Science PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Current Gene Therapy The Development of Targeted Therapies for Hepatocellular Cancer
Current Pharmaceutical Design Withania somnifera Phytochemicals Confer Neuroprotection by Inhibition of the Catalytic Domain of Human Matrix Metalloproteinase-9
Letters in Drug Design & Discovery Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine
Current Drug Metabolism Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
CNS & Neurological Disorders - Drug Targets